FENC
FENNEC PHARMACEUTICALS INC.
Company overview
- Market capitalization
- $380.37M
- Employees
- 35
- Latest publication
- 2026-09-29
About FENNEC PHARMACEUTICALS INC.
Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of ototoxicity in adolescent, young adult, and adult cancer patients receiving cisplatin-based treatment; and Norgine Pharma UK Limited. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 17,874,000USD | 15,108,000USD | 13,777,000USD | 12,462,000USD | 9,652,000USD | 8,751,000USD | 7,925,000USD | 6,974,000USD |
| Research Development | 118,000USD | 49,000USD | 20,000USD | 29,000USD | 107,000USD | 94,000USD | 50,000USD | 97,000USD |
| Selling General Administrative | 4,639,000USD | 3,186,000USD | — | 6,752,000USD | 6,956,000USD | 6,145,000USD | — | 6,121,000USD |
| Selling And Marketing Expenses | 10,659,000USD | 11,422,000USD | — | 5,210,000USD | 4,354,000USD | 2,947,000USD | — | 4,601,000USD |
| General And Administrative Expenses | 4,639,000USD | 3,186,000USD | — | 6,752,000USD | 6,956,000USD | 6,145,000USD | — | 6,121,000USD |
| Total Operating Expenses | 16,137,000USD | 15,227,000USD | 16,793,000USD | 12,651,000USD | 12,384,000USD | 9,559,000USD | 8,859,000USD | 12,176,000USD |
| Operating Income | 1,737,000USD | -119,000USD | — | -189,000USD | -2,732,000USD | -808,000USD | — | -5,202,000USD |
| Total Other Income Expense Net | 278,000USD | 320,000USD | — | -449,000USD | -420,000USD | -357,000USD | — | -533,000USD |
| Interest Income | 287,000USD | 339,000USD | — | 152,000USD | 171,000USD | 236,000USD | — | 516,000USD |
| Interest Expense | 3,000USD | 7,000USD | — | 586,000USD | 594,000USD | 592,000USD | — | 1,025,000USD |
| Income Before Tax | 2,015,000USD | — | — | — | — | — | — | — |
| Income Tax Expense | 42,000USD | — | — | — | — | — | — | — |
| Net Income | 1,973,000USD | 201,000USD | -5,144,000USD | -638,000USD | -3,152,000USD | -1,165,000USD | -60USD | -5,735,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosurePreliminary | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosurePreliminary | DisclosureDeterministicFinal |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 44,642,000USD | 47,538,000USD | 21,252,000USD | 1,535,000USD | 170,000USD | 170,000USD | 0USD | 0USD |
| Research Development | 250,000USD | 307,000USD | 56,000USD | 3,531,000USD | 4,981,000USD | 5,105,000USD | 5,607,000USD | 5,008,000USD |
| Selling General Administrative | 28,294,000USD | 23,053,000USD | 20,585,000USD | 17,722,000USD | 12,242,000USD | 12,950,000USD | 7,402,000USD | 5,401,000USD |
| Selling And Marketing Expenses | 18,616,000USD | 18,426,000USD | 12,123,000USD | 2,785,000USD | — | — | — | — |
| General And Administrative Expenses | 28,294,000USD | 23,053,000USD | — | — | — | — | — | — |
| Total Operating Expenses | 50,924,000USD | 44,970,000USD | 33,051,000USD | 24,187,000USD | 17,223,000USD | 18,055,000USD | 13,009,000USD | 10,409,000USD |
| Operating Income | -6,282,000USD | 2,568,000USD | -13,058,000USD | -22,738,000USD | -17,223,000USD | -17,885,000USD | -13,009,000USD | -10,409,000USD |
| Total Other Income Expense Net | -3,353,000USD | -2,639,000USD | -2,987,000USD | -976,000USD | -123,000USD | -224,000USD | 234,000USD | 521,000USD |
| Interest Income | 787,000USD | 1,682,000USD | 479,000USD | 195,000USD | 54,000USD | 87,000USD | 251,000USD | 515,000USD |
| Interest Expense | 2,080,000USD | 4,069,000USD | 3,394,000USD | 978,000USD | 126,000USD | 9,000USD | 0USD | 0USD |
| Income Before Tax | -9,635,000USD | -71,000USD | -16,045,000USD | -23,714,000USD | -17,346,000USD | -18,109,000USD | -12,775,000USD | -9,888,000USD |
| Income Tax Expense | 106,000USD | 365,000USD | 1USD | 1,125,000USD | 110,000USD | -187,000USD | -315,000USD | -348,000USD |
| Net Income | -9,741,000USD | -436,000USD | -16,045,000USD | -23,714,000USD | -17,346,000USD | -18,109,000USD | -12,460,000USD | -9,888,000USD |
| Cost Of Revenue | — | — | 1,259,000USD | 86,000USD | 0USD | — | — | 0USD |
| Gross Profit | — | — | 19,993,000USD | 1,449,000USD | 0USD | 170,000USD | — | 0USD |
| Net Interest Income | — | — | -2,893,000USD | -932,000USD | -72,000USD | -315,000USD | 251,000USD | 348,000USD |
| Tax Provision | — | — | 0USD | — | — | — | — | — |
| Net Income From Continuing Ops | — | — | -20,220,000USD | -23,714,000USD | -17,346,000USD | -18,109,000USD | -12,775,000USD | -9,888,000USD |
| Ebit | — | — | -12,651,000USD | -22,736,000USD | -17,236,000USD | -18,502,000USD | -13,009,000USD | -9,888,000USD |
| Ebitda | — | — | -12,364,000USD | -22,587,000USD | -17,220,000USD | -18,100,000USD | -12,945,000USD | 521,000USD |
| Depreciation And Amortization | — | — | 287,000USD | 149,000USD | 16,000USD | 402,000USD | 64,000USD | 10,409,000USD |
| Reconciled Depreciation | — | — | 287,000USD | 149,000USD | 16,000USD | 402,000USD | 64,000USD | — |
| Net Income Applicable To Common Shares | — | — | — | -23,714,000USD | -17,346,000USD | -18,109,000USD | -12,775,000USD | -9,888,000USD |
| Non Operating Income Net Other | — | — | — | — | -123,000USD | -224,000USD | 234,000USD | 521,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 75,753,000USD | 71,822,000USD | 70,551,000USD | 49,261,000USD | 44,876,000USD | 46,403,000USD | 44,946,000USD | 58,921,000USD |
| Cash And Equivalents | 41,249,000USD | 40,179,000USD | 36,788,000USD | 21,947,000USD | 18,705,000USD | 22,675,000USD | 26,634,000USD | 40,320,000USD |
| Total Current Assets | 72,500,000USD | 66,880,000USD | 67,043,000USD | 46,064,000USD | 40,794,000USD | 42,975,000USD | 44,124,000USD | 57,965,000USD |
| Other Current Assets | 1,976,000USD | 2,622,000USD | 1,731,000USD | 898,000USD | 965,000USD | 1,004,000USD | 466,000USD | 546,000USD |
| Other Non Current Assets | 666,000USD | 691,000USD | 717,000USD | 743,000USD | 768,000USD | 794,000USD | 2,438,000USD | 956,000USD |
| Total Liabilities | 33,311,000USD | 34,147,000USD | 35,079,000USD | 53,753,000USD | 52,339,000USD | 52,283,000USD | 50,818,000USD | 64,092,000USD |
| Total Current Liabilities | 12,394,000USD | 9,586,000USD | 10,518,000USD | 9,815,000USD | 8,414,000USD | 8,371,000USD | 6,919,000USD | 7,435,000USD |
| Other Current Liabilities | 3,696,000USD | 3,057,000USD | 5,635,000USD | 3,701,000USD | 2,225,000USD | 2,843,000USD | 3,428,000USD | 3,313,000USD |
| Total Stockholder Equity | 42,442,000USD | 37,675,000USD | 35,472,000USD | -4,492,000USD | -7,463,000USD | -5,880,000USD | -5,872,000USD | -5,171,000USD |
| Total Equity Including Noncontrolling Interest | 42,442,000USD | 37,675,000USD | 35,472,000USD | -4,492,000USD | -7,463,000USD | -5,880,000USD | -5,872,000USD | -5,171,000USD |
| Deferred Revenue | 3,182,000USD | 248,000USD | 248,000USD | 248,000USD | 248,000USD | 248,000USD | 248,000USD | 248,000USD |
| Deferred Revenue Non Current | 20,917,000USD | 24,561,000USD | 24,561,000USD | 24,561,000USD | 24,561,000USD | 24,561,000USD | 24,561,000USD | 24,561,000USD |
| Net Receivables | 23,266,000USD | 18,762,000USD | 23,221,000USD | 19,343,000USD | 17,502,000USD | 15,448,000USD | 12,884,000USD | 12,908,000USD |
| Accounts Payable | 5,516,000USD | 6,281,000USD | 4,635,000USD | 5,866,000USD | 5,941,000USD | 5,280,000USD | 3,241,000USD | 3,867,000USD |
| Common Stock | 193,190,000USD | 191,229,000USD | 189,906,000USD | 147,652,000USD | 146,165,000USD | 145,979,000USD | 145,608,000USD | 145,438,000USD |
| Retained Earnings | -227,248,000USD | -229,221,000USD | -229,422,000USD | -224,636,000USD | -223,998,000USD | -220,846,000USD | -219,681,000USD | -217,696,000USD |
| Accumulated Other Comprehensive Income | 1,243,000USD | 1,243,000USD | 1,243,000USD | 1,243,000USD | 1,243,000USD | 1,243,000USD | 1,243,000USD | 1,243,000USD |
| Short Term Debt | — | — | — | — | — | — | 2,000USD | 7,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 70,551,000USD | 44,946,000USD | 26,864,000USD | 26,939,000USD | 22,414,000USD | 31,417,000USD | 14,146,000USD | 22,950,000USD |
| Cash And Equivalents | 36,788,000USD | 26,634,000USD | — | — | — | — | — | — |
| Total Current Assets | 67,043,000USD | 44,124,000USD | 26,858,000USD | 26,728,000USD | 22,387,000USD | 31,417,000USD | 13,884,000USD | 22,950,000USD |
| Other Current Assets | 1,731,000USD | 466,000USD | 2,619,000USD | 833,000USD | 253,000USD | 1,073,000USD | 234,000USD | 169,000USD |
| Other Non Current Assets | 717,000USD | 2,438,000USD | — | — | — | — | — | — |
| Total Liabilities | 35,079,000USD | 50,818,000USD | — | — | — | — | — | — |
| Total Current Liabilities | 10,518,000USD | 6,919,000USD | 7,553,000USD | 4,609,000USD | 1,654,000USD | 2,347,000USD | 2,271,000USD | 1,637,000USD |
| Other Current Liabilities | 5,635,000USD | 3,428,000USD | — | — | — | — | — | — |
| Total Stockholder Equity | 35,472,000USD | -5,872,000USD | -11,622,000USD | -2,569,000USD | 15,772,000USD | 29,070,000USD | 11,875,000USD | 21,313,000USD |
| Total Equity Including Noncontrolling Interest | 35,472,000USD | -5,872,000USD | — | — | — | — | — | — |
| Deferred Revenue | 248,000USD | 248,000USD | — | — | — | — | — | — |
| Deferred Revenue Non Current | 24,561,000USD | 24,561,000USD | — | — | — | — | — | — |
| Net Receivables | 23,221,000USD | 12,884,000USD | 8,814,000USD | 1,545,000USD | 0USD | — | — | — |
| Accounts Payable | 4,635,000USD | 3,241,000USD | 3,778,000USD | 2,390,000USD | 777,000USD | 1,571,000USD | 1,612,000USD | 1,032,000USD |
| Common Stock | 189,906,000USD | 145,608,000USD | 144,307,000USD | 142,591,000USD | 140,801,000USD | 140,733,000USD | 106,392,000USD | 106,392,000USD |
| Retained Earnings | -229,422,000USD | -219,681,000USD | -219,245,000USD | -203,200,000USD | -179,486,000USD | -162,140,000USD | -144,031,000USD | -131,256,000USD |
| Accumulated Other Comprehensive Income | 1,243,000USD | 1,243,000USD | 1,243,000USD | 1,243,000USD | 1,243,000USD | 1,243,000USD | 1,243,000USD | 1,243,000USD |
| Short Term Debt | — | 2,000USD | 21,000USD | — | 12,000USD | — | — | — |
| Total Liab | — | — | 38,486,000USD | 29,508,000USD | 6,642,000USD | 2,347,000USD | 2,271,000USD | 1,637,000USD |
| Other Current Liab | — | — | 3,754,000USD | 2,219,000USD | 877,000USD | 776,000USD | 659,000USD | 605,000USD |
| Capital Stock | — | — | 144,307,000USD | 142,591,000USD | 140,801,000USD | 140,733,000USD | 106,392,000USD | 106,392,000USD |
| Other Assets | — | — | 0USD | 211,000USD | 27,000USD | 1,073,000USD | 262,000USD | 169,000USD |
| Cash | — | — | 13,269,000USD | 23,774,000USD | 21,100,000USD | 30,344,000USD | 13,650,000USD | 22,781,000USD |
| Cash And Short Term Investments | — | — | 13,269,000USD | 23,774,000USD | 21,100,000USD | 30,344,000USD | 13,650,000USD | 22,781,000USD |
| Current Deferred Revenue | — | — | -21,000USD | — | — | — | — | — |
| Net Debt | — | — | 17,685,000USD | 1,125,000USD | -16,112,000USD | -30,344,000USD | -13,650,000USD | -22,781,000USD |
| Short Long Term Debt Total | — | — | 30,954,000USD | 24,899,000USD | 5,000,000USD | — | — | — |
| Long Term Debt | — | — | 30,931,000USD | 24,899,000USD | 4,988,000USD | — | — | — |
| Inventory | — | — | 2,156,000USD | 576,000USD | 0USD | — | — | — |
| Common Stock Shares Outstanding | — | — | 26,574,000shares | 26,275,000shares | 26,006,000shares | 23,704,000shares | 19,896,000shares | 19,015,385shares |
| Non Current Assets Total | — | — | 6,000USD | 211,000USD | 27,000USD | 0USD | 262,000USD | 0USD |
| Non Current Liabilities Total | — | — | 30,933,000USD | 24,899,000USD | 4,988,000USD | 1,571,000USD | 1,612,000USD | 1,032,000USD |
| Non Currrent Assets Other | — | — | 6,000USD | 211,000USD | 27,000USD | — | 262,000USD | 0USD |
| Net Working Capital | — | — | 19,305,000USD | 22,119,000USD | 20,733,000USD | 29,070,000USD | 11,613,000USD | 21,313,000USD |
| Unclassified Equity | — | — | -82,234,000USD | -85,794,000USD | -87,587,000USD | -91,499,000USD | -58,121,000USD | -61,458,000USD |
| Deferred Long Term Liab | — | — | — | 211,000USD | 27,000USD | — | 262,000USD | — |
| Other Liab | — | — | — | 260,000USD | 4,988,000USD | — | — | — |
| Net Tangible Assets | — | — | — | -2,569,000USD | 15,772,000USD | 29,070,000USD | 11,875,000USD | 21,313,000USD |
| Unclassified Current Assets | — | — | — | — | 1,034,000USD | — | — | — |
| Unclassified Non Current Liabilities | — | — | — | — | -5,015,000USD | 1,571,000USD | 1,350,000USD | 1,032,000USD |
| Unclassified Non Current Assets | — | — | — | — | — | -1,073,000USD | — | — |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|
| Stock Based Compensation | 2,764,000USD | 4,511,000USD | 2,292,000USD | 3,937,000USD |
| Change To Account Receivables | 295,000USD | -8,982,000USD | -5,542,000USD | -7,698,000USD |
| Change To Inventory | -809,000USD | -1,417,000USD | -1,141,000USD | 514,000USD |
| Change To Liabilities | -1,058,000USD | 2,898,000USD | 1,497,000USD | -352,000USD |
| Change In Working Capital | 571,000USD | -7,689,000USD | -4,418,000USD | -6,986,000USD |
| Operating Cash Flow | 2,429,000USD | -6,511,000USD | -8,004,000USD | 28,454,000USD |
| Net Common Stock Issuance | -1,252,000USD | -161,000USD | -111,000USD | — |
| Unclassified Financing Cash Flow | 3,284,000USD | 1,985,000USD | 186,000USD | — |
| Financing Cash Flow | 2,032,000USD | 1,824,000USD | 75,000USD | -1,403,000USD |
| Change In Cash | 4,461,000USD | -4,687,000USD | -7,929,000USD | 27,051,000USD |
| End Cash Flow | 41,249,000USD | 21,947,000USD | 18,705,000USD | 40,320,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Stock Based Compensation | 990,000USD | 2,522,000USD | 2,219,000USD | 1,494,000USD | 798,000USD | 1,124,000USD | 1,821,000USD | 925,000USD |
| Change To Account Receivables | 4,512,000USD | -3,512,077USD | -3,440,000USD | -265,000USD | -5,277,000USD | -175,000USD | -4,200,000USD | -2,037,999USD |
| Change To Inventory | -291,000USD | 142,451USD | 624,000USD | -797,000USD | -344,000USD | 65,000USD | 502,000USD | -80,000USD |
| Change To Liabilities | -932,000USD | — | — | — | 1,454,000USD | — | — | — |
| Change In Working Capital | 4,407,000USD | -9,253,143USD | 7,280,000USD | -3,210,000USD | -4,119,000USD | 678,000USD | -1,746,000USD | -3,455,999USD |
| Operating Cash Flow | 2,379,000USD | — | — | — | -4,318,000USD | — | — | — |
| Net Common Stock Issuance | -311,000USD | — | — | — | -12,000USD | — | — | — |
| Unclassified Financing Cash Flow | 1,323,000USD | 23,174,297USD | — | — | 371,000USD | — | — | — |
| Financing Cash Flow | 1,012,000USD | — | — | — | 359,000USD | — | — | — |
| Change In Cash | 3,391,000USD | 14,841,000USD | 3,242,000USD | -3,970,000USD | -3,959,000USD | -13,686,000USD | -2,734,000USD | -8,130,000USD |
| End Cash Flow | 40,179,000USD | — | — | — | 22,675,000USD | — | — | — |
| Net Income | — | -4,787,000USD | -637,000USD | -3,152,000USD | — | -1,985,000USD | -5,735,000USD | -5,553,000USD |
| Depreciation | — | 1,000USD | 51,000USD | 25,000USD | — | 121,000USD | 46,000USD | 49,000USD |
| Other Non Cash Items | — | 5,555,143USD | -7,420,000USD | 1,157,000USD | — | -1,412,000USD | 3,408,000USD | -352,001USD |
| Total Cash From Operating Activities | — | -5,962,000USD | 1,493,000USD | -3,686,000USD | — | -1,474,000USD | -2,206,000USD | -8,387,000USD |
| Capital Expenditures | — | 0USD | 0USD | 0USD | — | 0USD | -3USD | -3USD |
| Free Cash Flow | — | -5,962,000USD | 1,493,000USD | -3,686,000USD | — | -1,474,000USD | -2,206,000USD | -8,387,000USD |
| Total Cash From Financing Activities | — | 20,803,000USD | 1,749,000USD | -284,000USD | — | -12,212,000USD | -528,000USD | 257,000USD |
| Begin Period Cash Flow | — | 21,947,000USD | 18,705,000USD | 22,675,000USD | — | 40,320,000USD | 43,054,000USD | 51,184,000USD |
| End Period Cash Flow | — | 36,788,000USD | 21,947,000USD | 18,705,000USD | — | 26,634,000USD | 40,320,000USD | 43,054,000USD |
| Other Cashflows From Financing Activities | — | -2,371,297USD | 1,920,405USD | -85,526USD | — | -12,203,000USD | -56,118USD | 347,000USD |
| Total Cashflows From Investing Activities | — | — | — | — | — | -3USD | 3USD | — |
| Sale Purchase Of Stock | — | — | — | — | — | -9,000USD | -528,000USD | -90,000USD |
| Other Cashflows From Investing Activities | — | — | — | — | — | -3USD | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Stock Based Compensation | 7,033,000USD | 5,061,000USD | 5,354,000USD | 4,220,000USD | 4,014,999USD | 2,791,000USD | 2,665,000USD | 1,825,000USD |
| Other Non Cash Items | -2,022,000USD | — | 1,427,000USD | 1,796,000USD | -768,999USD | 386,000USD | 481,000USD | 105,000USD |
| Change To Account Receivables | -12,440,000USD | -7,873,000USD | -7,269,000USD | -1,545,000USD | -1,545,000USD | -1,545,000USD | -1,545,000USD | — |
| Change To Inventory | -1,278,000USD | 579,000USD | -1,580,000USD | -576,000USD | -576,000USD | -576,000USD | -576,000USD | — |
| Change To Liabilities | 3,601,000USD | -863,000USD | — | 1,612,000USD | -794,000USD | -41,000USD | 634,000USD | 160,000USD |
| Change In Working Capital | -15,115,000USD | -7,035,000USD | -8,166,000USD | -509,000USD | -138,000USD | -663,000USD | 569,000USD | 132,000USD |
| Operating Cash Flow | -12,473,000USD | 26,980,000USD | — | — | — | — | — | — |
| Net Debt Issuance | -19,477,000USD | -13,000,000USD | — | — | — | — | — | — |
| Net Common Stock Issuance | -187,000USD | -176,000USD | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | 42,291,000USD | -439,000USD | — | — | — | -5,308,000USD | -4,915,000USD | -7,315,000USD |
| Financing Cash Flow | 22,627,000USD | -13,615,000USD | — | — | — | — | — | — |
| Change In Cash | 10,154,000USD | 13,365,000USD | -10,505,000USD | 2,674,000USD | -9,244,000USD | 16,694,000USD | -9,131,000USD | -5,479,000USD |
| End Cash Flow | 36,788,000USD | 26,634,000USD | — | — | — | — | — | — |
| Net Income | — | — | -16,045,000USD | -23,714,000USD | -17,346,000USD | -18,109,000USD | -12,775,000USD | -9,888,000USD |
| Depreciation | — | — | 287,000USD | 149,000USD | 16,000USD | 402,000USD | 64,000USD | — |
| Total Cash From Operating Activities | — | — | -17,143,000USD | -18,058,000USD | -14,222,000USD | -15,595,000USD | -9,060,000USD | -7,826,000USD |
| Capital Expenditures | — | — | -3USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | — | — | -17,143,000USD | -18,058,000USD | -14,222,000USD | -15,595,000USD | -9,060,000USD | -7,826,000USD |
| Net Borrowings | — | — | 4,997,000USD | 20,173,000USD | 4,986,000USD | 4,986,000USD | 4,986,000USD | 4,986,000USD |
| Total Cash From Financing Activities | — | — | 6,638,000USD | 20,732,000USD | 4,978,000USD | 32,289,000USD | -71,000USD | 2,347,000USD |
| Sale Purchase Of Stock | — | — | -78,000USD | -194,000USD | -8,000USD | 32,289,000USD | -71,000USD | 2,329,000USD |
| Begin Period Cash Flow | — | — | 23,774,000USD | 21,100,000USD | 30,344,000USD | 13,650,000USD | 22,781,000USD | 28,260,000USD |
| End Period Cash Flow | — | — | 13,269,000USD | 23,774,000USD | 21,100,000USD | 30,344,000USD | 13,650,000USD | 22,781,000USD |
| Other Cashflows From Financing Activities | — | — | 1,716,000USD | 753,000USD | -8,000USD | 322,000USD | -71,000USD | 2,347,000USD |
| Dividends Paid | — | — | — | -529,164USD | — | — | — | — |
| Issuance Of Capital Stock | — | — | — | — | 0USD | 31,967,000USD | — | 0USD |
| Cash And Cash Equivalents Changes | — | — | — | — | -9,244,000USD | 16,694,000USD | -9,131,000USD | -5,479,000USD |
| Investments | — | — | — | — | — | — | — | 0USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.